France vs Netherlands: Cause of death, by non-communicable diseases, ages 5-14
France
64.5%
in 2021
Netherlands
64.8%
in 2021
France rank
20th
Netherlands rank
19th
Cause of death, by non-communicable diseases, ages 5-14 over time
- France
- Netherlands
How they compare
Netherlands currently reports 64.8% against 64.5% in France, a difference of 0.3%.
Across all 6 years both countries report, Netherlands has been ahead every year.
France ranks 20th and Netherlands ranks 19th of 185 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.7% | 61.7% | 10.1% | Netherlands |
| 2010s | 65.8% | 70.8% | 5.0% | Netherlands |
| 2020s | 63.4% | 65.6% | 2.2% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, France or Netherlands?
- Netherlands, at 64.8% against 64.5% in France as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between France and Netherlands?
- 0.3%, with Netherlands ahead.
- How many years of comparable data are there for France and Netherlands?
- 6 years are reported by both, from 2000 to 2021.
- How do France and Netherlands rank globally for cause of death, by non-communicable diseases, ages 5-14?
- France ranks 20th and Netherlands ranks 19th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.